About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 20 record(s)
Req # A-2024-0094836
A copy of the Patented Medicine Prices Review Board’s response to the Standing Committee on Health report titled: The Patented Medicine Prices Review Board: Ensuring the Effectiveness of the Reform Process. The report can also be found here: https…Organization: Patented Medicine Prices Review Board Canada
December 2024
Req # A-2023-025599
For FY 2015-2022 (inclusive), how many investigations into prescription pricing on the basis that the pricing exceeded the guidelines resulted in a public hearing? Of those that resulted in a public hearing, in how many was the pricing found to be…Organization: Patented Medicine Prices Review Board Canada
July 2023
Req # A-2023-025896
For fiscal years 2015-2022 (inclusive), how many new patented medicines were reported to the board by Bayer, Inc.? From among those reports, how many included claims that a price exceeded the guidelines?Organization: Patented Medicine Prices Review Board Canada
July 2023
Req # A-2023-11914
Number of instances in which the ATIP unit used section 20(6) (the public interest override) of the Access to Information Act, as tallied by the documentation retained in accordance with the Manual. No time limit; assess based on period of available…Organization: Patented Medicine Prices Review Board Canada
April 2023
Req # A-2022-09059
Copies of all submissions or comments received in response to the PMPRB's 2022 Guidelines consultation, including any late consultation submissions received on December 6th or 7th. So this request runs from October 6th to December 7th, 2022. If…Organization: Patented Medicine Prices Review Board Canada
December 2022
Req # A-2021-24949
Copies of all records related to the board meeting regarding the consultation results update on September 1, 2021 as referenced in Douglas Clark's calendar.Organization: Patented Medicine Prices Review Board Canada
January 2022
Req # A-2021-24950
Copies of all communication plans, strategies or similar documents prepared by PMPRB staff between May 1, 2021 and December 20, 2021.Organization: Patented Medicine Prices Review Board Canada
January 2022
Req # A-2021-00001
Copies of all meeting minutes, presentations and speaking notes associated with the following 2018 meetings of the PMPRB Steering Committee on Modernization of Price Review Process Guidelines and the working group struck to inform that committee:…Organization: Patented Medicine Prices Review Board Canada
December 2021
Req # A-2021-10643
Provide the preparation documents (excluding PowerPoint), meeting summaries and emails related to meetings and communications between PMPRB executives and Biosimilars Canada over planned reforms to the PMPRB Guidelines from June 1, 2019 to June 7,…Organization: Patented Medicine Prices Review Board Canada
December 2021
Req # A-2021-10676
Provide the preparation documents (excluding PowerPoint), meeting summaries and emails related to meetings and communications between PMPRB executives and PDCI Market Access over planned reforms to the PMPRB Guidelines from June 1, 2019 to June 8,…Organization: Patented Medicine Prices Review Board Canada
December 2021